Ambrx Biopharma, Inc.
AMAM
Revenue
53.00k
▼-1.54M▼-96.68%
12 Months ChangeAssets
271.50M
▲124.52M▲84.72%
9 Months ChangeLiabilities
29.10M
▼-29.00k▼-0.09956%
9 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-03-12
Form 8-K
ID: 0000950157-24-000386
2024-03-07
Form 8-K
ID: 0001193125-24-061543
2024-03-06
Form 8-K
ID: 0001193125-24-060712
2024-02-22
Form 8-K
ID: 0001193125-24-042131
2024-01-08
Form 8-K
ID: 0001193125-24-003916
2023-12-01
Form 8-K
ID: 0000950170-23-067368
2023-11-13
Form 10-Q
ID: 0000950170-23-062916
2023-10-23
Form 8-K
ID: 0001193125-23-260814
2023-10-16
Form 8-K
ID: 0000950170-23-053584